Xbiotech Stock Odds of Future Stock Price Finishing Under 7.46
| XBIT Stock | USD 7.35 0.54 7.93% |
XBiotech |
XBiotech Target Price Odds to finish below 7.46
The tendency of XBiotech Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay under $ 7.46 after 90 days |
| 7.35 | 90 days | 7.46 | about 79.03 |
Based on a normal probability distribution, the odds of XBiotech to stay under $ 7.46 after 90 days from now is about 79.03 (This XBiotech probability density function shows the probability of XBiotech Stock to fall within a particular range of prices over 90 days) . Probability of XBiotech price to stay between its current price of $ 7.35 and $ 7.46 at the end of the 90-day period is about 7.16 .
Given the investment horizon of 90 days the stock has the beta coefficient of 2.87 . This entails as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, XBiotech will likely underperform. Additionally XBiotech has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. XBiotech Price Density |
| Price |
Predictive Modules for XBiotech
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as XBiotech. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.XBiotech Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. XBiotech is not an exception. The market had few large corrections towards the XBiotech's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold XBiotech, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of XBiotech within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.04 | |
β | Beta against Dow Jones | 2.87 | |
σ | Overall volatility | 0.48 | |
Ir | Information ratio | 0.04 |
XBiotech Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of XBiotech for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for XBiotech can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| XBiotech had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 300 K. Net Loss for the year was (24.56 M) with profit before overhead, payroll, taxes, and interest of 3.36 M. | |
| XBiotech currently holds about 225.79 M in cash with (18.73 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.42, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| XBiotech has a frail financial position based on the latest SEC disclosures | |
| Roughly 35.0% of the company outstanding shares are owned by insiders | |
| Latest headline from MacroaxisInsider: Disposition of 12308 shares by Han Queena of XBiotech at 4.16 subject to Rule 16b-3 |
XBiotech Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of XBiotech Stock often depends not only on the future outlook of the current and potential XBiotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. XBiotech's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 30.4 M | |
| Cash And Short Term Investments | 200 M |
XBiotech Technical Analysis
XBiotech's future price can be derived by breaking down and analyzing its technical indicators over time. XBiotech Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of XBiotech. In general, you should focus on analyzing XBiotech Stock price patterns and their correlations with different microeconomic environments and drivers.
XBiotech Predictive Forecast Models
XBiotech's time-series forecasting models is one of many XBiotech's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary XBiotech's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about XBiotech
Checking the ongoing alerts about XBiotech for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for XBiotech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| XBiotech had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 300 K. Net Loss for the year was (24.56 M) with profit before overhead, payroll, taxes, and interest of 3.36 M. | |
| XBiotech currently holds about 225.79 M in cash with (18.73 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.42, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| XBiotech has a frail financial position based on the latest SEC disclosures | |
| Roughly 35.0% of the company outstanding shares are owned by insiders | |
| Latest headline from MacroaxisInsider: Disposition of 12308 shares by Han Queena of XBiotech at 4.16 subject to Rule 16b-3 |
Additional Tools for XBiotech Stock Analysis
When running XBiotech's price analysis, check to measure XBiotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy XBiotech is operating at the current time. Most of XBiotech's value examination focuses on studying past and present price action to predict the probability of XBiotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move XBiotech's price. Additionally, you may evaluate how the addition of XBiotech to your portfolios can decrease your overall portfolio volatility.